In a recent CY Partners webinar, we brought together leaders from Quell Therapeutics, Touchlight Genetics, Carter Jonas, and Track Real Estate to explore a pressing question:
Is there enough lab space in the UK and are we building the right sort of facilities to support the pace of scientific innovation?

What followed was a sharp, honest discussion on the connection between scientific ambition in the UK and physical infrastructure. The demand for specialist lab facilities in key regions, risks slowing down biotech progress and investment.

We explored:
• The regional divide in lab availability and why some science clusters are hitting capacity.
• Creative solutions like shared labs, modular units, and academic partnerships bridging the gap.
• What industry and government need to do next to unlock future capacity.

The message was clear: if we want the UK to remain a global science leader, lab space can’t be an afterthought. Innovation needs infrastructure.

Watch the full webinar here: